Bempedoic Acid Pregnancy Surveillance Program
Purpose
Bempedoic acid pregnancy surveillance program
Conditions
- Pregnancy
- Hyperlipidemias
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Exposure to at least 1 dose of bempedoic acid or bempedoic acid/ezetimibe FCDP at any time during pregnancy (from first day of last menstrual period [LMP] to pregnancy outcome
Exclusion Criteria
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Other
Recruiting Locations
Evidera, PPD business unit
Morrisville, North Carolina 27560
Morrisville, North Carolina 27560
More Details
- Status
- Recruiting
- Sponsor
- Esperion Therapeutics, Inc.
Detailed Description
A surveillance study of females exposed to bempedoic acid or bempedoic acid/ezetimibe fixed combination drug product (FCDP) during pregnancy. Observational outcome data will be collected on pregnant females through pregnancy and infants through the first year of life.